Legal Representation
Attorney
Steven A. Abreu
USPTO Deadlines
Application History
13 events| Date | Code | Type | Description |
|---|---|---|---|
| May 2, 2025 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| May 2, 2025 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Apr 9, 2025 | ALIE | A | ASSIGNED TO LIE |
| Apr 9, 2025 | ALIE | A | ASSIGNED TO LIE |
| Apr 9, 2025 | ALIE | A | ASSIGNED TO LIE |
| Mar 22, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Mar 22, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Mar 22, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Mar 12, 2025 | DOCK | D | ASSIGNED TO EXAMINER |
| Jan 24, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Nov 6, 2024 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Sep 12, 2024 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
| Sep 12, 2024 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
house mark for pharmaceutical preparations for use in connection with the prevention and treatment of cancer, inflammatory conditions, immunological disorders, neoplastic conditions, rare genetic diseases, cardiovascular conditions, infectious diseases, and neurological conditions; House mark for pharmaceutical preparations; biomedical compounds for medical purposes, namely, peptides and miniproteins and cell-penetrating peptides and cell-penetrating miniproteins (CPMPs) arrays for diagnosing cancer, inflammatory conditions, immunological disorders, cardiovascular conditions, infectious diseases, and neurological conditions
Class 042
drug discovery services; Scientific research and development; providing information in the field of scientific research and development in the biotechnology and pharmaceutical fields; scientific research and development in the field of biotechnology and pharmaceuticals
Classification
International Classes
005
042